FDA says PT. Winson Prima Sejahtera's ready-to-eat yellowfin tuna seafood safety plan lacks pathogen and histamine controls.
What happened
FDA conducted a Foreign Remote Regulatory Assessment of the seafood processing facility on April 02 - 09, 2023. It found that the HACCP plan (seafood safety plan) for wild, frozen, vacuum packaged, ready-to-eat yellowfin tuna did not list pathogen growth including Salmonella, had a histamine critical limit that did not assure safety, and lacked consistent temperature monitoring and adequate corrective actions. The firm had not responded to the discussion items by the time of the letter.
What FDA found
The HACCP plan did not list pathogen growth, including Salmonella, as a hazard reasonably likely to occur for ready-to-eat raw tuna.
21 CFR 123.6(a) and (c)(1)The plan's critical limit at one control point did not give the safety assurance needed to prevent histamine formation.
21 CFR 123.6(c)(3)The firm did not consistently monitor internal temperatures at the receiving control point as its plan required.
21 CFR 123.6(b) and (c)(4)Corrective actions for histamine testing, decomposition, and internal temperatures did not address correcting the cause of deviations.
21 CFR 123.7(b)The histamine-testing corrective action did not state that none of the fish tested should have histamine at or above the firm's limit.
21 CFR 123.7(b)Records from August 2022 did not show when corrective actions were taken after histamine limits were exceeded, and no retest or rejection records were provided.
21 CFR 123.7(b)
What FDA wants
FDA asks the firm to respond in writing within 15 working days from receipt, outlining specific corrections and including a revised HACCP plan and five consecutive days of completed monitoring records for five production date codes. If all corrections cannot be completed in 15 days, the firm should explain the delay and when it will finish.
Who should pay attention
- U.S. importers of frozen ready-to-eat tuna
- brands and distributors sourcing seafood from Indonesian processors
- seafood processors with similar HACCP plans for histamine and temperature controls
This is a summary. Read the original letter on fda.gov.